Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement: help or hindrance?

× No keyword cloud information.

6 in total

Review 1. Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors: Inessa Schwab; Falk Nimmerjahn
Journal: Nat Rev Immunol Date: 2013-02-15 Impact factor: 53.106

Review 2. Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.

Authors: Saskia Meyer; Jeanette H W Leusen; Peter Boross
Journal: MAbs Date: 2014-10-30 Impact factor: 5.857

Review 3. Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.

Authors: Timothy M Pierpont; Candice B Limper; Kristy L Richards
Journal: Front Oncol Date: 2018-06-04 Impact factor: 6.244

4. Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength.

Authors: Sina Bondza; Anita Marosan; Sibel Kara; Josephine Lösing; Matthias Peipp; Falk Nimmerjahn; Jos Buijs; Anja Lux
Journal: Front Immunol Date: 2021-01-11 Impact factor: 7.561

5. Mechanisms of action of CD20 antibodies.

Authors: Peter Boross; Jeanette H W Leusen
Journal: Am J Cancer Res Date: 2012-11-20 Impact factor: 6.166

6. A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.

Authors: Alexander Grunenberg; Lisa M Kaiser; Stephanie Woelfle; Birgit Schmelzle; Andreas Viardot; Peter Möller; Thomas F E Barth; Rainer Muche; Jens Dreyhaupt; Markus Raderer; Barbara Kiesewetter; Christian Buske
Journal: BMC Cancer Date: 2021-06-29 Impact factor: 4.430

6 in total